Last updated on November 2017

Clostridium Difficile Vaccine Efficacy Trial


Brief description of study

The Clover trial is evaluating an investigational vaccine that may help to prevent Clostridium difficile infection. Participants in the study are adults 50 years of age and older, who are at risk of developing Clostridium difficile infection. The study will assess whether the vaccine prevents the disease, and whether it is safe and well tolerated. Each subject will receive 3 doses of Clostridium difficile vaccine or placebo and be followed for up to 3 years after vaccination for potential Clostridium difficile infection.

Detailed Study Description

Clostridium Difficile

Clinical Study Identifier: NCT03090191

Contact Investigators or Research Sites near you

Start Over

Pfizer CT.gov Call Center

Iizuka Hospital
Iizuka, Japan
6.62miles
  Connect »